Formation and speciation of nine haloacetamides, an emerging class of nitrogenous DBPs, during chlorination or chloramination

Haloacetamides (HAcAms) are an emerging class of nitrogenous disinfection by-products (N-DBPs) of health concern. However, there are very limited data on the formation and speciation of the nine bromine- and chlorine-containing haloacetamides (HAcAm9). In the study, their formation and speciation during chlor(am)ination were investigated for a group of waters with a range of specific ultraviolet absorbance at 254 nm (SUVA₂₅₄), dissolved organic nitrogen (DON), and bromide levels. The waters that were the least impacted by anthropogenic pollution had the lowest DON levels, the highest ratios of dissolved organic carbon (DOC) to DON, and exhibited the least HAcAm9 formation. DON/DOC may act as an indicator of HAcAm yields during chlorination. HAcAm9 exhibited more formation during chloramination in the low-SUVA waters with no bromide, relative to high-SUVA waters with bromide. The selected waters all formed primarily dihalogenated (di-) HAcAms, followed by trihalogenated (tri-) species and, to a much lesser extent, monohalogenated (mono-) HAcAms. Di-HAcAm formation had similar trends as that of HAcAm9; whereas chloramination formed more mono- and less tri-HAcAms than chlorination. Bromine utilization factors and bromine incorporation factor increased with decreasing and increasing bromide during either chlorination or chloramination, and bromine was easier to incorporate into tri-HAcAms during chloramination than chlorination.

Solid Phase Synthesis and Application of Labeled Peptide Derivatives: Probes of Receptor-Opioid Peptide Interactions

Solid phase synthetic methodology has been developed in our laboratory to incorporate an affinity label (a reactive functionality such as isothiocyanate or bromoacetamide) into peptides (Leelasvatanakij, L. and Aldrich, J. V. (2000) J. Peptide Res. 56, 80), and we have used this synthetic strategy to prepare affinity label derivatives of a variety of opioid peptides. To date side reactions have been detected only in two cases, both involving intramolecular cyclization. We have identified several peptide-based affinity labels for delta opioid receptors that exhibit wash-resistant inhibition of binding to these receptors and are valuable pharmacological tools to study opioid receptors. Even in cases where the peptide derivatives do not bind covalently to their target receptor, studying their binding has revealed subtle differences in receptor interactions with particular opioid peptide residues, especially Phe residues in the N-terminal "message" sequences. Solid phase synthetic methodology for the incorporation of other labels (e.g. biotin) into the C-terminus of peptides has also been developed in our laboratory (Kumar, V. and Aldrich, J. V. (2003) Org. Lett. 5, 613). These two synthetic approaches have been combined to prepare peptides containing multiple labels that can be used as tools to study peptide ligand-receptor interactions. These solid phase synthetic methodologies are versatile strategies that are applicable to the preparation of labeled peptides for a variety of targets in addition to opioid receptors.